New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide-Reference-Cited by-同舟云学术

New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide

Published:2015-02-17 Issue:2 Volume:20 Page:143-148
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

van Boxtel W.¹²,Bulten B. F.²³,Mavinkurve-Groothuis A. M. C.⁴⁵,Bellersen L.⁶,Mandigers C. M. P. W.⁷,Joosten L. A. B.⁸,Kapusta L.⁹¹⁰,de Geus-Oei L. F.²³,van Laarhoven H. W. M.¹¹¹

Affiliation:

1. Department of Medical Oncology and

2. Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands,

3. MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands,

4. Department of Pediatric Hematology and Oncology, Radboud University Medical Center, Nijmegen, The Netherlands,

5. Department of Pediatric Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands,

6. Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands,

7. Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands,

8. Department of Internal Medicine and

9. Department of Children’s Heart Centre, Radboud University Medical Center, Nijmegen, The Netherlands,

10. Pediatric Cardiology Unit, E. Wolfson Medical Centre, Holon, Israel, and

11. Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.3109/1354750X.2015.1040839

Reference33 articles.

1. Biomarkers in Heart Failure

2. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy

3. Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy

4. Coenzyme Q10 for Prevention of Anthracycline-Induced Cardiotoxicity

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond;Biomolecules;2024-02-07

2. New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review;Cancers;2023-06-22

3. Doxorubicin Cardiotoxicity: Preclinical and Clinical Circulating Protein Markers;Biomarkers in Toxicology;2023

4. Cardiotoxicity: Importance of biomarkers;Arhiv za farmaciju;2023

5. Galectin-3 and Myeloperoxidase May Monitor Cancer-Therapy-Related Cardiotoxicity? A Systematic Review and Meta-Analysis;Biomolecules;2022-11-30